Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma

Annals of the Academy of Medicine Singapore

Volumn 25, Issue 1, 1996, Pages 22-30

  Lin, Y ^a,e   Shi, C Y ^a   Li, B ^b   Soo, B H ^a   Mohammed Ali, S ^a   Wee, A ^c   Oon, C J ^a   Mack, P O P ^d   Chan, S H ^a  

^a Department of Microbiology ^*

^b Inst of Molecular and Cell Biology

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d SINGAPORE GENERAL HOSPITAL   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Aflatoxin; Hepatitis B vrius; Hepatocarcinogenesis; Mutation; PCR SSCP; Restriction fragment length polymorphism

Indexed keywords

DNA;

ANIMAL; CAT; CELL CULTURE; GENETIC POLYMORPHISM; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; ISOLATION AND PURIFICATION; LIVER CELL CARCINOMA; LIVER TUMOR; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; REVIEW; TUMOR SUPPRESSOR GENE; VIROLOGY;

ANIMALS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CATS; DNA; GENES, P53; GENES, RETINOBLASTOMA; GENES, TUMOR SUPPRESSOR; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029689347     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. DiBisceglie A M, Rustgi V K, Hoofnagle J H, Dusheiko G M, Lotze M T. Hepatocellular carcinoma. Ann Intern Med 1988; 108:390-401.
2. Harris C C. Hepatocellular carcinogenesis:recent advances and speculation. Cancer Cells 1990; 2:146-8.
3. Salto I, Miyanmura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87:6547-9
4. Bishop J M Molecular themes in oncogenesis. Cell 1991; 64:235-48.
5. Harris CC Chemical and physical carcinogenesis: advances and prospectives for the 1990s. Cancer Res 1991; 51.5023s-44s.
6. Levine AJ, Momand J, Finlay C A. The p53 tumour suppressor gene. Nature 1991; 351:453-6
7. Weinberg R A. Tumour suppressor genes. Science 1991, 254:1138-46.
8. Baker S J, Fearon E R, Nigro J M, Hamilton S R, Preisinger A C, Jessup J M, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989; 244:217-21.
9. Nigro J M, Baker S J, Preisinger A C, Jessup J M, Hostetter R, Cleary K, et al Mutations in the p53 gene occur in diverse human tumour types. Nature 1989; 342:705-8
10. Hollstein M, Sidransky D, Vogelstein B, Harris C C p53 mutations in human cancers. Science 1991; 259:49-53.
11. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350:429-31.
12. Hsu I C, Metcalf R A, Sun T, Welsh J T, Wang N J, Harris C C. Mutational Kotspot in the p53 gene in human hepatocellular carcinoma. Nature 1991; 350:427-8.
13. Ozturk M, collaborators p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 1991; 338:1356-9.
14. Scorsone K A, Zhou Y Z, Butel J S, Slagle B L. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res 1992; 52:1635-8.
15. Coursaget P, Depril N, Chabaud M, Nandi R, Mayelo V, LeCann P, et al. High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal Br J Cancer 1993; 67:1395-7.
16. Li D Z, Cao Y Q, He L P, Wang N J, Gu J R. Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis 1993; 14:169-73.
17. Fujimoto Y, Hampton L L, Wirth P J, Wang N J, Xie J P, Thorgeirsson S S. Alterations of tumour suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res 1994; 54:281-5.
18. Foster P L, Eisenstadt E, Miller J H. Base substitution mutations induced by metabolically activated aflatoxin Bl. Proc Natl Acad Sci USA 1983; 80:2695-8
19. Murakami Y, Hayashi K, Hirohashi S, Sekiya T. Aberrations of the tumour suppressor p53 and rerinoblastoma genes in human hepatocellular carcinomas Cancer Res 1991; 51:5520-5.
20. Hosono S, Chou M J, Lee C S, Shih C. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas. Oncogene 1993; 8:491-6.
21. T'Ang A, Vartey J M, Chakraborty S, Murphree A L, Fung Y K T. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 1988; 242:263-6.
22. Fung Y K T, Murphree A L, T'Ang A, Qian J, Hinrichs S H, Benedict W F. Structural evidence for the authenticity of the human retinoblastoma gene. Science 1987; 236:1657-61.
23. Hong F D, Huang H J S, To H, Young L J S Y, Oro A, Bookstein R, et al. Structure of the human retinoblastoma gene Proc Natl Acad Sci USA 1989; 86:5502-6.
24. Huh N, Utakoji T. Production of HBs-antigen by two new human hepatoma cell lines and its enhancement by dexamethasone. Jpn J Cancer Res 1981; 72:178-9.
25. Doi I. Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma. Jpn J Cancer Res 1976, 67:1-10.
26. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res 1982; 42:3858-63.
27. Fogh J, Trempe G. New human tumour cell lines. In Fogh J, editor Human Tumour Cell Lines in Vitro. New York: Plenum Press, 1976:115-59.
28. Aden D P, Fogel A, Plotkin S, Damjanov I, Knowles B B. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 1979; 282:615-6.
29. Watanabe T, Morizane T, Tsuchimoto K, Inagaki Y, Munakata Y, Nakamura T, et al. Establishment of a cell line (HCC-M) from a human hepatocellular carcinoma. Int J Cancer 1983; 32:141-6.
30. Saito H, Morizane T, Watanabe T, Kagawa T, Iwabuchi N, Kumagai N, et al. Establishment of a human cell line (HCC-T) from a patient with hepatoma bearing no evidence of hepatitis B or A virus infection. Cancer 1989,64:1054-60.
31. Prozeskey O, Brits C, Grabow W. In vitro culture of cell lines from Australia antigen positive and negative hepatoma patients. In: Saunders S, Terblanche J, editors. Liver. London: Pitman Medical, 1973:358-60.
32. Alexander J J, Bey E M, Geddes E W, Lecatsas G. Establishment of a continuously growing cell line from primary carcinoma of the liver. South Afr Med J 1976; 50:2124-8.
33. Stevenson D, Lin J H, Tong M J, Marshall G J. Characteristics of a cell line (Tong/HCC) established from a human hepatocellular carcinoma. Hepatology 1987; 6:1291-5.
34. Tay N, Chan S H, Ren E C. Detection of integrated hepatitis B virus DNA in hepatocellular carcinoma cell lines by nonradioactive in situ hybridization. J Med Virol 1990; 30:266-71.
35. Feinberg A P, Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132:6-13.
36. Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. New York, Cold Spring Harbor. Cold Spring Harbor Laboratory, 1989.
37. Lamb P, Crawford L. Characterization of the human p53 gene Mol Cell Biol 1986; 6:1379-85.
38. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5:874-9.
39. Bressac B, Galvin K M, Liang T J, Isselbacher K J, Wands T R, Ozturk M Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87:1973-7.
40. Hosono S, Lee C S, Chou M J, Yang C S, Shih C. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell Unes. Oncogene 1991; 6:237-43.
41. Hsu C I, Tokiwa T, Bennett W, Metcalf R A, Welsh J A, Sun T, et al. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell Unes. Carcinogenesis 1993; 14:987-92.
42. Volkmann M, Hofmann W J, Muller M, Rath U, Otto G, Zentgraf H, et al. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation. Oncogene 1994; 9:195-204.
43. Puisieux A, Galvin K, Troalen F, Bressac B, Marcais C, Galun E, et al. Retinoblastoma and p53 tumour suppressor genes in human hepatoma cell lines. FASEB J 1993; 7.1407-13.
44. Sherman M, Shafritz D A. Hepatitis B virus and hepatocellular carcinoma: molecular biology and mechanistic considerations Semin Liver Dis 1984; 4:98-112.
45. Bréchot C. Hepatitis B virus (HBV) and hepatocellular carcinoma. HBV DNA status and its implications. J Hepatol 1987; 4:269-79.
46. Hayward N K, Walker G J, Graham W, Cooksley E Hepatocellular carcinoma mutation. Nature 1991; 352-764.
47. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res 1992; 52:6358-64.
48. Sheu J C, Huang G T, Lee P H, Chung J C, Chou H C, Lai M Y, et al Mutation of p53 gene in hepatocellular carcinoma in Taiwan Cancer Res 1992; 52:6098-100.
49. Patel P, Stephenson J, Sheuer P J, Francis G E. p53 codon 249ser mutation in hepatocellular carcinoma patients with low aflatoxin exposure. Lancet 1992; 339:881.
50. Kress S, Jahn U R, Buchmann A, Bannasch P, Schwaz M. p53 mutations in human hepatocellular carcinomas from Germany. Cancer Res 1992; 52:3220-3
51. Hollstein M C, Wild C P, Bleicher F, Chutimataewin S, Harris C C, Srivatanakul P, et al. p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand. Int J Cancer 1993, 53:51-5.
52. Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell D W, Ikenega M, et al. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res 1993; 53:368-72.
53. Challen C, Lunec J, Warren W, Collier J, Bassendine M F. Analysis of the p53 tumour-suppressor gene in hepatocellular carcinomas from Britain. Hepatology 1992; 16:1362-6.
54. Ng I O L, Chung L P, Tsang S W Y, Lam C L, Lai E C S, Fan S T, et al. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese. Oncogene 1994; 9:985-90.
55. Shih C Y, Phang T W, Lin Y, Wee A, Li B, Lee H P, et al. Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore. Br J Cancer 1995; 72:146-9.
56. Wild C P, Jansen T A M, Cova L, Montesano R Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial aetiopathogenesis of primary hepatocellular carcinoma (PHC) with particular reference to hepatitis B virus (HBV). Environ Health Perspect 1993; 99:115-22.
57. Bosch F X, Muñoz N. Prospects for epidemiological studies on hepatocellular cancer as a model for assessing viral and chemical interactions. In: Bartsch H, Hemminki K, O'Neill I K, editors. Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention Lyon: International Agency for Research on Cancer, 1988:427-38.
58. Shieh Y S C, Nguyen C, Vocal M V, Chu H W. Tumour-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma. Int J Cancer 1993; 54:558-62
59. Zhou Y Z, Slagle B L, Donehower L A, van Tuinen P, Ledbetter D H, Butel J S. Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma. J Virol 1988; 62:4224-31.
60. Slagle B L, Zhou Y Z, Butel JS. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res 1991; 51:49-54.
61. Levine A J. The p53 protein and its interactions with the oncogene products of the small DNA tumour viruses. Virology 1990; 177:419-26
62. Feitelson M A, Zhu M, Duan L X, London W T. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 1993; 8:1109-17.
63. Kim C M, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis-B virus induces liver cancer in transgenic mice. Nature 1991; 351:317-20.
64. Hino O, Tabata S, Motta Y. Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA Proc Natl Acad Sci USA 1991; 88:9248-52.
65. 2 cDNA. Mol Carcinog 1992; 6:140-7
66. McMahon G, Davis E F, Huber L J, Kim Y, Wogan G N. Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver rumours Proc Natl Acad Sci USA 1990; 87:1104-8.
67. Fujimoto Y, Hampton L L, Luo L, Wirth P J, Thorgeirsson S S. Low frequency of p53 gene mutation in tumour induced by aflatoxin Bl in nonhuman primates Cancer Res 1992; 52:1044-6.
68. Augilar F, Pourzand C, Hussain P, Cerutti P, Aflatoxin B1 induces the transversion of G→T in codon 249 of the p53 tumour suppressor gene in human hepatocytes Proc Natl Acad Sci USA 1993; 90:8586-90.
69. Essigmann J M, Croy R G, Nadzan A M, Busby W F, Reinhold V N, Buchi G, et al. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. Proc Natl Acad Sci USA 1977; 74:1870-4.
70. Puisieux A, Lin S, Groopman J, Ozturk K M Selective targeting of p53 gene mutational hotspots in human cancers by biologically defined carcinogens. Cancer Res 1991; 51:6185-9.
71. Cheng K C, Cahill D S, Kasai H, Nashimura S, Loeb L A. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions J Biol Chem 1992, 267:166-72.
72. Ross R K, Yuan J M, Yu M C, Wogan G N, Qian G S, Tu J T, et al Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339:943-6